General
A COVID-19 vaccine will be a game-changer for international travel. But it won’t fix everything
The United Kingdom this week became the first country to approve the Pfizer/BioNTech COVID-19 vaccine for widespread use. Following a review by the country’s drug regulator, the UK government announced it will begin rolling out the vaccine next week.
Other countries are likely to follow soon, authorising the Pfizer/BioNTech vaccine and possibly other leading candidates too. Australia’s Therapeutic Goods Administration says it’s continuing to assess the Pfizer/BioNTech data.
The world has been eagerly awaiting a COVID vaccine, touted since early in the pandemic as our best hope of returning to “normal”. A big part of this is the resumption of international travel.
Certainly, an effective vaccine brings this prospect much closer. But…
-
General21 hours agoAustralian economy still vulnerable to US bond turmoil
-
Business20 hours ago2 ASX 200 shares that could be top buys for growth
-
General7 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business17 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks